Ultromics

Oxford, United Kingdom · Founded 2017 · Privately Held (backing)

Developer of an artificial intelligence-based cardiovascular diagnostic technology designed to detect heart failure and amyloidosis. Ultromics is based in Oxford, United Kingdom and was founded in 2017. Its last reported valuation was $131 million in Jul 2025. It has raised $136 million.

Last reported valuation
$131.0M
Oct 2026
Priced at
—
Total raised
$135.8M
Last round
—

Who backs Ultromics?

27 investors
InvestorType
GVVenture capital
Tech Nation GroupOther
Future Planet CapitalVenture capital
University of Oxford—
LightrockVenture capital
Oxford Science EnterprisesVenture capital
Optum VenturesVenture capital
Mayo ClinicOther
UPMC EnterprisesVenture capital
Nova Capital (Italy)Growth equity
+ 17 more investors · a free account shows the complete list
The directory is free. Investor activity — the working column — is Pro.Unlock prospecting columns

Membership and data by Private Market View

Ultromics investors

27 investors are on record for Ultromics, including GV, Tech Nation Group, Future Planet Capital and University of Oxford. By type, the record holds 6 venture capital firms and 1 hedge fund.

Free account
More of Ultromics with a free account
  • ·The complete investor list: 27 names
  • ·Watch Ultromics: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

For fundraisers
Work this list, don’t just read it

These 27 firms already write checks for companies like Ultromics. Build the wider list: every firm that has backed a company like this one, ranked by how often and how recently.

Find investors like these →

Membership and data by Private Market View